{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:31:50Z","timestamp":1792009910006,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Health Industry Science and Technology Program","award":["2025HY0058"],"award-info":[{"award-number":["2025HY0058"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073529"],"award-info":[{"award-number":["82073529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574079"],"award-info":[{"award-number":["82574079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key Research and Development Program of Guangdong Province, China","award":["2019B20227003"],"award-info":[{"award-number":["2019B20227003"]}]},{"name":"the 5010 Program for Clinical Researches of the Sun Yat-sen University","award":["2007032"],"award-info":[{"award-number":["2007032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04834-8","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:39:10Z","timestamp":1776411550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrated serum proteomic and liver genomic analyses identify molecular signatures associated with metabolic dysfunction-associated steatotic liver disease: a multi-cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jinjian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanglong","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieteng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6560-4890","authenticated-orcid":false,"given":"Ju-Sheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1658-5528","authenticated-orcid":false,"given":"Yu-ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"4834_CR1","first-page":"1277","volume":"28","author":"H Tilg","year":"2025","unstructured":"Tilg H, Petta S, Stefan N, Targher G, Niu L, Thiele M, et al. Metabolic dysfunction-associated steatotic liver disease in adults: a review noninvasive proteomic biomarkers for alcohol-related liver disease. JAMA. 2025;28:1277\u201387.","journal-title":"JAMA"},{"key":"4834_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","volume":"20","author":"LA Orci","year":"2022","unstructured":"Orci LA, Sanduzzi-Zamparelli M, Caballol B, Sapena V, Colucci N, Torres F, et al. Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. Clin Gastroenterol Hepatol. 2022;20:283-292.e210.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4834_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Petracca G, Beatrice G, Csermely A, Tilg H, Byrne CD, et al. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut. 2022;71:778\u201388.","journal-title":"Gut"},{"key":"4834_CR4","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1038\/s41591-025-03799-0","volume":"31","author":"M Jara","year":"2025","unstructured":"Jara M, Norlin J, Kj\u00e6r MS, Almholt K, Bendtsen KM, Bugianesi E, et al. Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis. Nat Med. 2025;31:3128\u201340.","journal-title":"Nat Med"},{"key":"4834_CR5","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.2337\/dc23-2145","volume":"47","author":"P Yao","year":"2024","unstructured":"Yao P, Iona A, Pozarickij A, Said S, Wright N, Lin K, et al. Proteomic analyses in diverse populations improved risk prediction and identified new drug targets for type 2 diabetes. Diabetes Care. 2024;47:1012\u20139.","journal-title":"Diabetes Care"},{"key":"4834_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/HEP.0000000000000300","volume":"78","author":"YJ Abozaid","year":"2023","unstructured":"Abozaid YJ, Ayada I, van Kleef LA, Vallerga CL, Pan Q, Brouwer WP, et al. Plasma proteomic signature of fatty liver disease: the Rotterdam Study. Hepatology. 2023;78:284\u201394.","journal-title":"Hepatology"},{"key":"4834_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s43587-024-00753-6","volume":"5","author":"WS Liu","year":"2025","unstructured":"Liu WS, You J, Chen SD, Zhang Y, Feng JF, Xu YM, et al. Plasma proteomics identify biomarkers and undulating changes of brain aging. Nat Aging. 2025;5:99\u2013112.","journal-title":"Nat Aging"},{"key":"4834_CR8","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1038\/s41591-025-03798-1","volume":"31","author":"HS Oh","year":"2025","unstructured":"Oh HS, Le Guen Y, Rappoport N, Urey DY, Farinas A, Rutledge J, et al. Plasma proteomics links brain and immune system aging with healthspan and longevity. Nat Med. 2025;31:2703\u201311.","journal-title":"Nat Med"},{"key":"4834_CR9","doi-asserted-by":"crossref","unstructured":"Liu J, Xiao S, Hu S, Huang R, Chen L, Tomlinson JW, et al. Dissecting metabolic dysfunction- and alcohol-associated liver disease (MetALD) using proteomic and metabolomic profiles. J Hepatol. 2025;83:1035\u201345.\u00a0","DOI":"10.1016\/j.jhep.2025.05.026"},{"key":"4834_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102085","volume":"6","author":"W De Nardo","year":"2025","unstructured":"De Nardo W, Lee O, Johari Y, Bayliss J, Pensa M, Miotto PM, et al. Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH. Cell Rep Med. 2025;6:102085.","journal-title":"Cell Rep Med"},{"key":"4834_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2022.11.029","volume":"78","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, Williams SA, Lavine JE, Neuschwander-Tetri BA, Alexander L, Ostroff R, et al. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2023;78:693\u2013703.","journal-title":"J Hepatol"},{"key":"4834_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188793","volume":"15","author":"L Niu","year":"2019","unstructured":"Niu L, Geyer PE, Wewer Albrechtsen NJ, Gluud LL, Santos A, Doll S, et al. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. Mol Syst Biol. 2019;15:e8793.","journal-title":"Mol Syst Biol"},{"key":"4834_CR13","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","volume":"54","author":"G Sveinbjornsson","year":"2022","unstructured":"Sveinbjornsson G, Ulfarsson MO, Thorolfsdottir RB, Jonsson BA, Einarsson E, Gunnlaugsson G, et al. Multiomics study of nonalcoholic fatty liver disease. Nat Genet. 2022;54:1652\u201363.","journal-title":"Nat Genet"},{"key":"4834_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156082","volume":"163","author":"K Stefanakis","year":"2025","unstructured":"Stefanakis K, Mingrone G, George J, Mantzoros CS. Accurate non-invasive detection of MASH with fibrosis F2-F3 using a lightweight machine learning model with minimal clinical and metabolomic variables. Metabolism. 2025;163:156082.","journal-title":"Metabolism"},{"key":"4834_CR15","doi-asserted-by":"publisher","unstructured":"Zhang S, Xu H, Li M, Yuan G, Nie J, Zhang Q, et al. An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC. J Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.jhep.2025.10.026.","DOI":"10.1016\/j.jhep.2025.10.026"},{"key":"4834_CR16","doi-asserted-by":"crossref","unstructured":"Ling CW, Zhong H, Zeng FF, Chen G, Fu Y, Wang C, et al. Cohort profile: Guangzhou Nutrition and Health Study (GNHS): a population-based multi-omics study. J Epidemiol. 2023;34:301\u20136.","DOI":"10.2188\/jea.JE20230108"},{"key":"4834_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol. 2022;18:55\u201366.","journal-title":"Nat Rev Endocrinol"},{"key":"4834_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","volume":"69","author":"R Loomba","year":"2020","unstructured":"Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020;69:1343\u201352.","journal-title":"Gut"},{"key":"4834_CR19","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1007\/s00330-019-06072-4","volume":"29","author":"J Gu","year":"2019","unstructured":"Gu J, Liu S, Du S, Zhang Q, Xiao J, Dong Q, et al. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol. 2019;29:3564\u201373.","journal-title":"Eur Radiol"},{"key":"4834_CR20","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1264-1281.e1264.","journal-title":"Gastroenterology"},{"key":"4834_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"4834_CR22","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"key":"4834_CR23","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1021\/acs.analchem.3c00338","volume":"95","author":"M Tang","year":"2023","unstructured":"Tang M, Huang P, Wu L, Zhou P, Gong P, Liu X, et al. Comprehensive evaluation and optimization of the data-dependent LC-MS\/MS workflow for deep proteome profiling. Anal Chem. 2023;95:7897\u2013905.","journal-title":"Anal Chem"},{"key":"4834_CR24","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/hep.31995","volume":"74","author":"K Kozumi","year":"2021","unstructured":"Kozumi K, Kodama T, Murai H, Sakane S, Govaere O, Cockell S, et al. Transcriptomics identify thrombospondin-2 as a biomarker for NASH and advanced liver fibrosis. Hepatology. 2021;74:2452\u201366.","journal-title":"Hepatology"},{"key":"4834_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","volume":"18","author":"M Ahrens","year":"2013","unstructured":"Ahrens M, Ammerpohl O, von Sch\u00f6nfels W, Kolarova J, Bens S, Itzel T, et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 2013;18:296\u2013302.","journal-title":"Cell Metab"},{"key":"4834_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03617-0","volume":"5","author":"N Zhao","year":"2022","unstructured":"Zhao N, Zhuo M, Tian K, Gong X. Protein-protein interaction and non-interaction predictions using gene sequence natural vector. Commun Biol. 2022;5:652.","journal-title":"Commun Biol"},{"key":"4834_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02264-8","volume":"22","author":"R Ietswaart","year":"2021","unstructured":"Ietswaart R, Gyori BM, Bachman JA, Sorger PK, Churchman LS. GeneWalk identifies relevant gene functions for a biological context using network representation learning. Genome Biol. 2021;22:55.","journal-title":"Genome Biol"},{"key":"4834_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1157114","volume":"14","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, He W, Fan X, Liang J, Cao Z, Li L. Serum afamin levels in predicting gestational diabetes mellitus and preeclampsia: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1157114.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4834_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.670425","volume":"12","author":"T Kurdiova","year":"2021","unstructured":"Kurdiova T, Balaz M, Kovanicova Z, Zemkova E, Kuzma M, Belan V, et al. Serum afamin a novel marker of increased hepatic lipid content. Front Endocrinol (Lausanne). 2021;12:670425.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4834_CR30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1515\/cclm-2022-0777","volume":"60","author":"N Pitk\u00e4nen","year":"2022","unstructured":"Pitk\u00e4nen N, Finkenstedt A, Lamina C, Juonala M, K\u00e4h\u00f6nen M, M\u00e4kel\u00e4 KM, et al. Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease. Clin Chem Lab Med. 2022;60:243\u201351.","journal-title":"Clin Chem Lab Med"},{"key":"4834_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/ijms19020603","volume":"19","author":"M Del Ben","year":"2018","unstructured":"Del Ben M, Overi D, Polimeni L, Carpino G, Labbadia G, Baratta F, et al. Overexpression of the vitronectin V10 subunit in patients with nonalcoholic steatohepatitis: implications for noninvasive diagnosis of NASH. Int J Mol Sci. 2018;19:603.","journal-title":"Int J Mol Sci"},{"key":"4834_CR32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/hep.20838","volume":"42","author":"ZM Younossi","year":"2005","unstructured":"Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology. 2005;42:665\u201374.","journal-title":"Hepatology"},{"key":"4834_CR33","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/hep.32631","volume":"77","author":"A Deprince","year":"2023","unstructured":"Deprince A, Hennuyer N, Kooijman S, Pronk ACM, Baug\u00e9 E, Lienard V, et al. Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism. Hepatology. 2023;77:1287\u2013302.","journal-title":"Hepatology"},{"key":"4834_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/gastro\/goz011","volume":"7","author":"YB Wang","year":"2019","unstructured":"Wang YB, Zhou BX, Ling YB, Xiong ZY, Li RX, Zhong YS, et al. Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma. Gastroenterol Rep (Oxf). 2019;7:354\u201360.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"4834_CR35","doi-asserted-by":"publisher","first-page":"758","DOI":"10.14309\/ajg.0000000000000138","volume":"114","author":"M Sarkar","year":"2019","unstructured":"Sarkar M, VanWagner LB, Terry JG, Carr JJ, Rinella M, Schreiner PJ, et al. Sex hormone-binding globulin levels in young men are associated with nonalcoholic fatty liver disease in midlife. Am J Gastroenterol. 2019;114:758\u201363.","journal-title":"Am J Gastroenterol"},{"key":"4834_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2024.08.009","volume":"82","author":"YJ Liu","year":"2025","unstructured":"Liu YJ, Kimura M, Li X, Sulc J, Wang Q, Rodr\u00edguez-L\u00f3pez S, et al. ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD\/MASH. J Hepatol. 2025;82:174\u201388.","journal-title":"J Hepatol"},{"key":"4834_CR37","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.1038\/s41467-024-50660-y","volume":"15","author":"BK Jeong","year":"2024","unstructured":"Jeong BK, Choi WI, Choi W, Moon J, Lee WH, Choi C, et al. A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma. Nat Commun. 2024;15:6506.","journal-title":"Nat Commun"},{"key":"4834_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105532","volume":"111","author":"H Casta\u00f1\u00e9","year":"2025","unstructured":"Casta\u00f1\u00e9 H, Jim\u00e9nez-Franco A, Hern\u00e1ndez-Aguilera A, Mart\u00ednez-Navidad C, Cambra-Cort\u00e9s V, Onoiu AI, et al. Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis. EBioMedicine. 2025;111:105532.","journal-title":"EBioMedicine"},{"key":"4834_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3350\/cmh.2023.0449","volume":"30","author":"S Oh","year":"2024","unstructured":"Oh S, Baek YH, Jung S, Yoon S, Kang B, Han SH, et al. Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression. Clin Mol Hepatol. 2024;30:247\u201362.","journal-title":"Clin Mol Hepatol"},{"key":"4834_CR40","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1093\/eurheartj\/ehae407","volume":"45","author":"Y Huang","year":"2024","unstructured":"Huang Y, Wang C, Zhou T, Xie F, Liu Z, Xu H, et al. Lumican promotes calcific aortic valve disease through H3 histone lactylation. Eur Heart J. 2024;45:3871\u201385.","journal-title":"Eur Heart J"},{"key":"4834_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep4.1789","volume":"6","author":"S Subudhi","year":"2022","unstructured":"Subudhi S, Drescher HK, Dichtel LE, Bartsch LM, Chung RT, Hutter MM, et al. Distinct hepatic gene-expression patterns of NAFLD in patients with obesity. Hepatol Commun. 2022;6:77\u201389.","journal-title":"Hepatol Commun"},{"key":"4834_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41574-024-00970-4","volume":"20","author":"RC Baxter","year":"2024","unstructured":"Baxter RC. Endocrine and cellular physiology and pathology of the insulin-like growth factor acid-labile subunit. Nat Rev Endocrinol. 2024;20:414\u201325.","journal-title":"Nat Rev Endocrinol"},{"key":"4834_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111422","volume":"40","author":"S Lv","year":"2022","unstructured":"Lv S, Zhou Y, Chen J, Yuan H, Zhang ZN, Luan B. Hepatic ER stress suppresses adipose browning through ATF4-CIRP-ANGPTL3 cascade. Cell Rep. 2022;40:111422.","journal-title":"Cell Rep"},{"key":"4834_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101073","volume":"6","author":"M Khoury","year":"2024","unstructured":"Khoury M, Guo Q, Furuta K, Correia C, Meroueh C, Kim Lee HS, et al. Glycogen synthase kinase 3 activity enhances liver inflammation in MASH. JHEP Rep. 2024;6:101073.","journal-title":"JHEP Rep"},{"key":"4834_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101820","volume":"5","author":"S Sabatini","year":"2024","unstructured":"Sabatini S, Sen P, Carli F, Pezzica S, Rosso C, Lembo E, et al. Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis. Cell Rep Med. 2024;5:101820.","journal-title":"Cell Rep Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04834-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04834-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04834-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:52:43Z","timestamp":1780631563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04834-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4834"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04834-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was performed in accordance with the Declaration of Helsinki. The protocol of the Guangzhou Nutrition and Health Study was approved by the Institutional Review Board of the School of Public Health, Sun Yat-sen University (No. SYSU-2018\u2013048). Ethical approval for participant enrollment and biosample collection was granted by the Institutional Review Board of Zhejiang Provincial People\u2019s Hospital (No. 2021KY044). Written informed consent was obtained from all participants before study inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}